Ardelyx reported $31.21M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Abbott USD 6.8B 1.72B Mar/2026
Amgen USD 12.04B 2.91B Mar/2026
Ardelyx USD 31.21M 36.79M Mar/2026
aTyr Pharma USD 10.01M 735K Mar/2026
Corcept Therapeutics USD 108.74M 11.76M Mar/2026
Curis USD 10.14M 10.14M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
TG Therapeutics USD 442.21M 242.7M Mar/2026
United Therapeutics USD 1.28B 277.4M Mar/2026
Xoma USD 143.9M 7.68M Jun/2024